Glucose Profiles in Women With Polycystic Ovary Syndrome
Recruiting · NCT07483723 · Interventional (participants receive a specific treatment) · Lead sponsor: Centre Hospitalier Universitaire, Amiens
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
Polycystic ovary syndrome is a very common condition that is associated with metabolic complications. Patients with polycystic ovary syndrome exhibit insulin resistance and are at greater risk to develop type 2 diabetes. This syndrome is heterogeneous, classified according to 4 phenotypes (A-D). It seems that certain phenotypes are less exposed to insulin resistance and metabolic complications. However, only a few studies have evaluated the glucose profile according to phenotype. New technologies now make it possible to monitor glucose levels continuously. The aim of this project is to evaluate glucose profile parameters using continuous glucose monitoring, and to compare these profiles according to different PCOS phenotypes.
Who can take part
Inclusion criteria
- Age \> 18 years at inclusion criteria
- Patient with polycystic ovary syndrome, defined by the presence of at least 2/3 irregular menstrual cycles, clinical or biological hyperandrogenism, polycystic ovary morphology (pelvic ultrasound) or elevated AMH levels, after the exclusion of other disorders.
- Agreed to carry the FSL pro
- Signed informed consent
Exclusion criteria
- Pregnancy, breast-feeding
- Differential diagnoses: hyperprolactinemia, dysthyroidism, Cushing's syndrome, congenital adrenal hyperplasia, virilizing tumor (ovarian or adrenal), intake of exogenous androgens
- Pre-existing diabetes
- Patient treated within 3 months prior to inclusion/data collection with estrogen-progestin contraception, progestin contraception, antidiabetic drugs, inositol, antiandrogen
Where it is running
1 location listed.
- CHRU Amiens - Salouël, France